Mahesh Krishnan is Group Vice President of Research and Development at DaVita and co-leads the DaVita Venture Group. He founded the venture group and previously served as DaVita's first International Chief Medical Officer.
One email when Mahesh's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMahesh Krishnan is Group Vice President of Research and Development at DaVita and co-leads the DaVita Venture Group. He founded the venture group and previously served as DaVita's first International Chief Medical Officer.
Mahesh Krishnan invests through DaVita Venture Group, which writes checks of $10M to $30M.
A warm intro from a founder DaVita Venture Group backed works best. A short LinkedIn note with one line on traction is the next best route.
practicing nephrologist at Virginia Nephrology Group; Global Development Leader for Epogen and Executive Director, Medical Policy at Amgen Inc..
Last updated 2026-10-15. Is this you? Ask for a correction.